TWYNSTA 80 mg / 5 mg Tablets (28 Tablets)
Active Ingredients:
Telmisartan 80 mg – Angiotensin II Receptor Blocker (ARB)
Amlodipine Besylate 5 mg – Calcium Channel Blocker (Dihydropyridine class)
Therapeutic Class: Antihypertensive combination
Dosage Form: Oral tablet
TWYNSTA is indicated for the treatment of:
Essential hypertension in adult patients whose blood pressure is not adequately controlled by telmisartan or amlodipine monotherapy
Cardiovascular risk reduction in patients at risk of heart disease with high blood pressure
Telmisartan blocks the angiotensin II type 1 (AT1) receptor, preventing vasoconstriction and aldosterone release, thus lowering blood pressure
Amlodipine inhibits calcium ion influx into vascular smooth muscle, causing vasodilation and reduced peripheral resistance
Together, they provide a synergistic blood pressure-lowering effect by acting on complementary mechanisms.
Recommended dose: One tablet once daily
Should be taken at the same time each day, with or without food
Not recommended as initial therapy — indicated when monotherapy is insufficient
Contraindicated in pregnancy (especially 2nd and 3rd trimesters)
Caution in patients with renal or hepatic impairment, heart failure, or volume depletion
Monitor blood pressure, renal function, and electrolytes during treatment
Common: dizziness, peripheral edema, flushing, fatigue, hypotension
Less common: back pain, increased heart rate, nausea, rash, elevated potassium
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.